Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 2Stomach Neoplasms 2Rectal Neoplasms 2Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Anus Neoplasms 1

Interventions

Fluorouracil 26Radiotherapy 18Mitomycin 17Cisplatin 12Capecitabine 12pembrolizumab 10Magnetic Resonance Spectroscopy 9Cyclophosphamide 9Radiation 8Paclitaxel 8Biopsy 8fludarabine 7Specimen Handling 7Nivolumab 7Drug Therapy 7Carboplatin 7Surveys and Questionnaires 6Cetuximab 6Papillomavirus Vaccines 5dehydroftorafur 4aldesleukin 4Vaccines 4Radiotherapy, Intensity-Modulated 4Observation 4Irinotecan 4Watchful Waiting 3Taxes 3Oxaliplatin 3Light Coagulation 3Ipilimumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anus Neoplasms × Diphenhydramine × Gastrointestinal × Clear all
NCT04432597 2026-05-18

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
39 enrolled
GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡